Allspring Global Investments Holdings, LLC Vincerx Pharma, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$0.0 - $0.0 $0 - $0	-7,285 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$0.0 - $0.0 $0 - $0	-866 Reduced 10.62%	7,285 $0
Q4 2021 Jan 28, 2022	BUY	$0.0 - $0.0 $0 - $0	8,151 New	8,151 $83,000

Others Institutions Holding VINC

# of Institutions

Shares Held

11M

Call Options Held

Put Options Held

Armistice Capital, LLC New York, NY

2.7M
Shares

$513,760
0.03% of portfolio
Prosight Management, LP Dallas, TX

2.21M
Shares

$419,235
0.43% of portfolio
Sage Rhino Capital LLC

1.7M
Shares

$323,648
0.28% of portfolio
Rock Springs Capital Management LP Baltimore, MD

892K
Shares

$169,426
0.02% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

674K
Shares

$128,096
0.0% of portfolio

View Full List

About Vincerx Pharma, Inc.

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $4.03M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

More about VINC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account